Background
==========

Since Alfzelius reported that infertile males whose sperm cilia were immortal had the triad of Kartagener syndrome, primary cilia were discovered to be the key player underlying organ laterality \[[@b1-amjcaserep-14-20]\]. Here, we describe two situs inversus totalis males with cystic kidney disease who reached end stage renal disease (ESRD) in middle age in the absence of any family history of polycystic kidney disease (PKD). Situs inversus is an uncommon complication of cystic kidney diseases, with 28 such cases reported since 1981. Only three genes, *INVS* (*NPHP2*), *NPHP3* and *PKD2* have been proved to be responsible for some cases, while the responsible genes in many others are still unknown. In mutation screening analysis of *INVS, IFT88, PKD2, UMOD, NPHP3*, no pathogenic mutations were detected. Some mutations of other genes that encode protein expression in primary cilia in both node and kidney are expected to be present in these patients, and will require further investigation in future.

Case Reports
============

Patient 1
---------

A 54-year-old Japanese man developed severe azotemia and anemia and required emergent hemodialysis and transfusion. On a regular chest X-ray obtained at the age of 20 years, situs inversus had been pointed out. At 47 years. bilateral kidney cysts and renal insufficiency were detected on a regular medical check-up. He had no history of sinusitis or bronchiectasis. A chest X-ray revealed dextracardia and cardiomegaly ([Figure 1A](#f1-amjcaserep-14-20){ref-type="fig"}). Abdominal CT scan showed situs inversus totalis of all the abdominal organs and bilateral kidney cysts, but the number and sizes of the cysts were small ([Figure 1B](#f1-amjcaserep-14-20){ref-type="fig"}). There were no extrarenal cysts. He has no family member with PKD or situs inversus. His parents were not consanguineous. He has two biological children. His karyotype was normal.

Patient 2
---------

This Japanese man started regular hemodialysis at the age of 45 years. He was the third child of non-consanguineous parents. From the age of two years he developed frequent bronchitis, sinusitis and otitis media, and by his teens had developed hearing impairment that required a hearing aid. Because he refused to consult any physicians despite his longstanding ill health, situs inversus and polycystic kidneys were not detected until one year before he needed hemodialysis. At the same time bronchiectasis was detected by chest CT and he was diagnosed with Kartagener syndrome. His grandfather had situs inversus but there was no family history of PKD. He has two biological children. A chest X-ray ([Figure 1C](#f1-amjcaserep-14-20){ref-type="fig"}) and an abdominal CT scan ([Figure 1D](#f1-amjcaserep-14-20){ref-type="fig"}) revealed situs inversus totalis and bilateral multiple renal and hepatic cysts. After 10 years of regular hemodialysis, he died of acute myocardial infarction at the age of 55 years. Autopsy was performed then. [Figures 2](#f2-amjcaserep-14-20){ref-type="fig"} and [3](#f3-amjcaserep-14-20){ref-type="fig"} shows the macroscopic and microscopic findings of the postmortem autopsy of patient 2. The kidneys were enlarged to 28×11 cm (left) and 28×13cm (right) and contained numerous and variously sized cysts separated by very thin parenchyma. Variously sized cysts were present in the left-right reversed liver too. The pancreatic tail was atrophic, but the pancreas contained no cysts. In kidney specimens cysts of various sizes were prominent, with few glomeruli with no particular features. In the interstitium, atrophic and dilated tubules and calcified veins were present. All of these findings were compatible with those of end-stage kidneys due to Autosomal dominant polycystic kidney disease (ADPKD). The liver showed variously sized cysts, which consisted of a layer of biliary epithelium. The pancreas showed mild fibrotic change that was attributed to the chronic pancreatitis associated with the renal failure. There was no dysplastic change in the pancreas. In the lungs there were many bronchiectatic regions, the result of repeated inflammation characteristic of Kartagener syndrome. [Figure 4](#f4-amjcaserep-14-20){ref-type="fig"} shows cilia staining of patient 2 kidney ([Figure 4A](#f4-amjcaserep-14-20){ref-type="fig"}) along with that of an ESRD patient due to noncystic kidney disease ([Figure 4B](#f4-amjcaserep-14-20){ref-type="fig"}) and ESRD patients receiving hemodialysis due to ADPKD ([Figure 4C](#f4-amjcaserep-14-20){ref-type="fig"}). In patient 2, decreased and shortened primary cilia were observed in dilated renal tubular epithelial cells, although this finding is similar to that in ADPKD patients receiving hemodialysis.

No pathogenic mutation was discovered in the sequencing analysis of *INVS*, *PKD2*, *IFT88, UMOD* or *NPHP3* in both patients. Prior to the genetic analysis, informed consent was obtained from both patients. Detailed methods of genetic and pathological testing are available upon request.

Discussion
==========

[Table 1](#t1-amjcaserep-14-20){ref-type="table"} shows reported cases of situs inversus and cystic kidney diseases from the PubMed database. There have been a total of 28 comorbid cases reported so far, which can be divided into three groups: Renal dysplasia group (12 cases), Nephronophthisis (NPHP) group (13 cases) and PKD group (3 cases). The biggest difference between the groups is the age at renal disease onset. Renal dysplasia patients are found mostly in the gestational period with all of them dying in the fetal or neonatal period and none surviving for longer than 10 days. Nephronophthisis groups are diagnosed in the infantile or juvenile periods. ADPKD patients reach ESRD in adulthood. *INVS* and *NPHP3* mutations were detected in 3 and 2 NPHP patients respectively. Although almost all *invs* mutated mice manifest situs inversus \[[@b2-amjcaserep-14-20]\], the incidence of situs inversus is not high in humans with *INVS* mutation. Only 3 of 32 NPHP patients carrying *INVS* mutation showed situs inversus.

It would be natural to conclude a diagnosis of ADPKD in the present two patients who started hemodialysis therapy at the age of 54 and 45 years respectively. However some features in the present patients differ from those usually seen in ADPKD including absence of family history of ADPKD in both patients. Sizes of kidneys and numbers of kidney cysts in patient 1 were small for age as compared to usual ADPKD. Patient 2 had features of typical Kartagener syndrome. Extra renal cysts are common in ADPKD, but none were noted in patient 1. So the present two patients do not meet the criteria of ADPKD and differ from the two ADPKD patients reported by Bataille \[[@b3-amjcaserep-14-20]\]. Besides, the phenotypes of the two present patients are quite different.

The phenotype of Medullary cystic kidney disease (MCD) is similar to that of nephronophthisis. Affected patients reach ESRD in their forties to fifties. It is caused by at least two genes, one of which is Uromodulin (*UMOD*). *UMOD* has been found to be located in cilia\[[@b4-amjcaserep-14-20]\], although no mutations in *UMOD* gene were found in the present cases.

A striking point is that even the same gene mutation in the same family may cause different phenotypes. Among 12 related individuals with renal dysplasia carrying the same homozygous *NPHP3* mutation, only one had situs inversus\[[@b5-amjcaserep-14-20]\]. Both of the two pairs of independent *PKD2* family siblings sharing the same mutation had discordance of situs inversus in the report of Bataille\[[@b3-amjcaserep-14-20]\]. The same homozygous *INVS* mutation (Arg899X) in two siblings caused situs inversus discordantly and another independent patient with the same mutation did not show situs inversus either \[[@b6-amjcaserep-14-20]\]. On the other hand, all of three siblings manifested situs inversus in the report of Balci \[[@b7-amjcaserep-14-20]\] with unknown genetic abnormalities. So it is difficult to assume the mutated gene from the phenotype of a patient because syndromes of cystic kidney diseases combined with situs inversus comprise a very heterogeneous disease spectrum.

In some animals with cilia-related gene mutations there have been descriptions of the presence of no cilia or extremely short primary cilia, \[[@b8-amjcaserep-14-20],[@b9-amjcaserep-14-20]\], and this prompted us to check the cilia of patient 2. An extremely decreased number of and shortened primary cilia were detected in the kidneys of patient 2. However, this finding cannot be considered specific for this patient, since a similar picture is observed in the kidneys of ADPKD patients receiving hemodialysis.

The occurrence of situs inversus is decided by the direction of nodal ciliary movement during embryogenesis \[[@b10-amjcaserep-14-20]\]. Although the situs abnormality can be caused by mutation of a ciliary gene, other modifier genes or environmental factors also likely contribute. The existence of another mutation in another gene may be one explanation for the phenomenon\[[@b11-amjcaserep-14-20]\]. Numerous genes that express proteins in cilium and centrosome have been discovered and the numbers of such genes are still increasing. 13 genes have been proven to be responsible for NPHP, but account for only about 30% of cases, which implicates other as yet undiscovered genes in NPHP \[[@b12-amjcaserep-14-20]\]. However the mechanisms of such gene complexes are still equivocal.

Conclusions
===========

We describe two patients with situs inversus comorbid with cystic kidney disease that are different from any other previously reported cases. Although no genetic evidence was obtained, this syndrome may fall into a kind of cilia dysfunction syndrome. To prove this, analysis of a greater range of cilia related genes will be required in future, Such studies may also provide hints to the formation of left-right asymmetry.
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![Chest X-rays of patient 1 (**A**) and patient 2 (**C**) revealed dextracardia. (**B**) Abdominal CT scan of patient 1 shows situs inversus of all the abdominal organs and bilateral kidney cysts. Note small numbers of cysts, small kidneys, and absence of cysts in liver. (**D**) Abdominal CT scan of patient 2 revealed situs inversus totalis and multiple bilateral renal and hepatic cysts](amjcaserep-14-20-g001){#f1-amjcaserep-14-20}

![Macroscopic images of autopsy findings of patient 2. Bilateral kidneys are enlarged and filled with numerous cysts (**A** -- left kidney, **B** -- right kidney). Many cysts exist in left-right reversed liver too (**C**). There are no cysts in the pancreas, and the pancreatic tail is atrophic due to marked fat infiltration (**D**).](amjcaserep-14-20-g002){#f2-amjcaserep-14-20}

![Microscopic images of autopsy findings of patient 2. (**A**) Kidneys are filled with cysts of various sizes, among which atrophic and dilated tubules and calcified veins (✰) persist. (**B**) Only a few glomeruli remain with no signs of glomerulonephritis.\
**Figure 3C--E.** Microscopic images of autopsy findings of patient 2. (**C**) Liver has variously sized cysts consisting of a layer of biliary epithelium. Among the cysts there are many biliary micro hamartomas (arrow) and a subtle fibrous interstitium. (**D**) Bronchiectasis is present in the lungs. (**E**) Pancreas has mild fibrotic change and atrophy of lobules.](amjcaserep-14-20-g003){#f3-amjcaserep-14-20}

![Cilia staining of patient 2 (**A**) and ESRD patient due to noncystic kidney disease (**B**) and ESRD patient receiving HD due to ADPKD (**C**). In patient 2 and the ADPKD patient, decreased and shortened primary cilia were observed compared with the non-cystic kidney disease patient.](amjcaserep-14-20-g004){#f4-amjcaserep-14-20}

###### 

Reported cases of situs inversus comorbid with cystic kidney disease.

  **Case No**   **Sex**   **CS**   **Ethnic origin**     **Age[^a^](#tfn3-amjcaserep-14-20){ref-type="table-fn"}**   **Other complications**                                                            **Responsible gene**                                            **Category[^b^](#tfn4-amjcaserep-14-20){ref-type="table-fn"}**   **Ref**
  ------------- --------- -------- --------------------- ----------------------------------------------------------- ---------------------------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------- ------------------------------------
  1             F         N.D.     Japan                 --/35 gw/--/1 hr                                            COA, PDA, aortic stenosis, pulmonary stenosis                                      unknown                                                         D                                                                (Yoshikawa et al., 1981)
  2             F         N.D.     USA                   --/40 gw/--/1 day                                                                                                                              unknown                                                         D                                                                (Bernstein et al., 1987)
  3             M         No       Japan                 --/35 gw/--/10 days                                                                                                                            unknown                                                         D                                                                (Hiraoka et al., 1988)
  4             M         N.D.     Canada                --/32 gw/--/3 min                                           Chondrodysplasia, absent right kidney, polydactyly                                 unknown                                                         D                                                                (Fraser et al., 1989)
  5             F         N.D.     USA                   --/37 gw/--/stillborn                                       Multisystem fibrosis                                                               unknown                                                         D                                                                (Pinar and Rogers, 1992)
  6             M         Yes      Turkey                --/38 gw/--/stillborn                                       Ventriculomegaly of brain, bowing of the lower limbs and clavicles                 unknown                                                         D                                                                (Balci et al., 1999)
  7             F         Yes      Turkey                --/18 gw/--/ terminated                                     Same as No 6 (sibling)                                                             unknown                                                         D                                                                (Balci et al., 1999)
  8             F         Yes      Turkey                --/20 gw/--/ terminated                                     Same as No 6 (sibling)                                                             unknown                                                         D                                                                (Balci et al., 2000)
  9             M         N.D.     Taiwan                --/20 gw/--/stillborn                                       Potters sequences, agenesis of bilateral ureters                                   unknown                                                         D                                                                (Huang and Chen, 2000)
  10            F         No       Turkey                1 mo/1 mo/1 mo/--                                           Capillary hemangioma                                                               unknown                                                         D                                                                (Mir and Akil, 2003)
  11            N.D       Yes      Turkey                --/--/14 mo/--                                              VSD                                                                                INVS                                                            N                                                                (Otto et al., 2003)
  12            N.D       No       France                --/29 gw/--/--                                              Asplenia,CNS malformation[^c^](#tfn5-amjcaserep-14-20){ref-type="table-fn"}, DWM   *CEP260*(?)[^d^](#tfn6-amjcaserep-14-20){ref-type="table-fn"}   D                                                                (Baala et al., 2007)
  13            M         No       Japan                 21 y/11 y/Cr 1.62/--                                        Asphyxiating thoracic dystrophy                                                    unknown                                                         N                                                                (Okada et al., 2008)
  14            F         N.D.     Vietnam               12 y/1 mo/3 mo/--                                           Postaxial polydactyly,                                                             *NPHP3*                                                         N (D)[^e^](#tfn7-amjcaserep-14-20){ref-type="table-fn"}          (Bergmann et al., 2008)
  15            M         No       India                 10 mo/10 mo/Cr 0.7/--                                                                                                                          unknown                                                         P[^f^](#tfn8-amjcaserep-14-20){ref-type="table-fn"}              (Jayakrishnan and Devarajan, 2008)
  16            N.D       No       France                --/18 mo/18 mo/--                                                                                                                              INVS                                                            N                                                                (Tory et al., 2009)
  17            N.D       No       Switzerland           --/--/9 mo/--                                               Absence epilepsy                                                                   unknown                                                         N                                                                (Tory et al., 2009)
  18            N.D       Yes      Old Amish Community   --/34 gw/34 gw/29 days                                                                                                                         *NPHP3*                                                         N (D)[^e^](#tfn7-amjcaserep-14-20){ref-type="table-fn"}          (Simpson et al., 2009)
  19            F         N.D.     Reunion Island        --/31 gw/--/ terminated                                     VSD                                                                                unknown                                                         D                                                                (Alessandri et al., 2009)
  20            F         No       Belgium               31 y/10 y/11 y/--                                           Corrected TGA                                                                      *INVS*                                                          N                                                                (Bellavia et al., 2010)
  21            F         No       France                64 y/35 y/59 y/--                                                                                                                              *PKD2*                                                          P                                                                (Bataille et al., 2011)
  22            M         No       France                54 y/54 y/Cr 2.0/--                                                                                                                            PKD2                                                            P                                                                (Bataille et al., 2011)

CS -- consanguineous; N.D. -- no data available; COA -- Coarctation of Aorta; PDA -- Patent ductus arteriosus; VSD -- Ventricular septal defect; CNS -- central nervous system; DWM -- Dandy-Walker malformation; TGA -- Transposition of the great arteries.

Six NPHP cases with no clinical data available are not shown (Otto et al., 2008). Cases diagnosed with known cilia-related syndromes (Syndromes such as Bardet-Biedl syndrome, Ellis-van Creveld syndrome, hemifacial microsomia) are not included.

-- Age at report/diagnosis/ESRF/death. When patient has not reached ESRF, the serum Cr value (mg/dl) is shown;

-- Category of kidney disease D: Renal Dysplasia N: Nephronophthisis P: Polycystic kidney disease;

-- Occipital meningocele, Hydrocephaly, arhinencephaly, cerebellar vermis hypoplasia, cystic V4;

-- Although his DNA was not available, his sibling with Meckel syndrome without situs inversus had compound heterozygous mutations of *CEP260*;

-- Renal lesion of case No 14 was reported to be renal dysplasia. So the two cases with *NPHP3* mutation might be more appropriately included in the renal dysplasia category;

-- Bilateral kidneys enlarged to about 10cm. He is assumed to have ARPKD.
